Holen Sie sich die Stockscreener-App
123.48
1.79%
2.17
Handel nachbörslich:
122.51
-0.97
-0.79%
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
Assessing TransMedics Group (TMDX) Valuation After Recent Share Price Pullback - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out - ACCESS Newswire
2026-03-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Reach Out | NDAQ:TMDX | Press Release - Stockhouse
Analysts Raise TransMedics Group, Inc. (TMDX) Price Targets After Q4 Results - Yahoo Finance
Blair William & Co. IL Lowers Stake in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fieldview Capital Management LLC Acquires New Position in TransMedics Group, Inc. $TMDX - MarketBeat
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - AOL.com
12 Best Under-the-Radar Stocks to Buy According to Hedge Funds - Insider Monkey
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX) - Seeking Alpha
TransMedics Group (TMDX) Analyst Ratings Update: Stifel Raises P - GuruFocus
TransMedics: Numb Reaction To Extraordinary Fundamentals (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $130.00 - MarketBeat
Stifel raises TransMedics stock price target to $130 on liver strength - Investing.com
Assessing TransMedics Group (TMDX) Valuation After Recent Short Term Share Price Weakness - Yahoo Finance
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
4 Top Stocks Long-Term Investors Should Buy in March - The Globe and Mail
Lovell, TransMedics director, sells $178k in TMDX stock - Investing.com Nigeria
Weill David sells TransMedics (TMDX) shares worth $524,294 - Investing.com Nigeria
Weill David sells TransMedics (TMDX) shares worth $524,294 By Investing.com - Investing.com India
Insider Sell: Stephanie Lovell Sells Shares of TransMedics Group Inc (TMDX) - GuruFocus
Stephanie Lovell Sells 1,193 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) Director David Weill Sells 3,571 Shares - MarketBeat
TransMedics Group Signals Strong Growth in Earnings Call - TipRanks
TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Earnings Momentum with Bullish Technical Setup - ChartMill
A Look At TransMedics Group (TMDX) Valuation After Strong Results And Optimistic Revenue Guidance - simplywall.st
Anil Ranganath Sells 864 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Insider Selling: TransMedics Group (NASDAQ:TMDX) CFO Sells 375 Shares of Stock - MarketBeat
Nicholas Corcoran Sells 2,966 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) CFO Sells $1,065,211.56 in Stock - MarketBeat
The medtech firm’s latest quarter showed organ demand – and profits – continuing to rise. - Finimize
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS - MarketBeat
Why TransMedics Group (TMDX) Is Up 9.2% After Strong 2025 Results And 2026 Outlook - Sahm
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TD Cowen Health Care Conference - marketscreener.com
TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance - timothysykes.com
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
TransMedics Shares Surge Amid Strong Q4 Financial Performance - StocksToTrade
TransMedics’ Shares Surge on Strong Q4 Results and Price Target Raises - StocksToTrade
TransMedics Stock Surges as Analysts Raise Price Targets Amid Strong Earnings - timothysykes.com
TransMedics Stock Surges After Outstanding Q4 Earnings and Strategic Expansion Plans - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9%What's Next? - MarketBeat
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics provides information on impact of release of valuation allowance on deferred tax assets on previously reported quarterly results - marketscreener.com
TransMedics clarifies Q4 tax benefit impact on earnings - Investing.com
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PR Newswire
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group, Inc. (TMDX): A bull case theory - MSN
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):